Literature DB >> 12220187

RNA methyltransferases utilize two cysteine residues in the formation of 5-methylcytosine.

Michelle Y King1, Kent L Redman.   

Abstract

Proteins that have sequence homology with known RNA m(5)C methyltransferases contain two conserved cysteines, each of which lies within a sequence that bears similarity to a methyltransferase active site. Other enzymes that transfer a methyl group to carbon 5 of a pyrimidine nucleotide, such as the bacterial DNA m(5)C methyltransferases, utilize their single conserved cysteine residue to form a covalent Michael adduct with carbon 6 of the pyrimidine ring during catalysis. We present a model for the utilization of two cysteines in catalysis by RNA m(5)C methyltransferases. It is proposed that one thiol acts in a classical fashion by forming a covalent link to carbon 6 of the pyrimidine base, while the other cysteine assists breakdown of the covalent adduct. Therefore, alteration of the assisting cysteine is anticipated to stabilize the covalent enzyme-RNA intermediate. The model was conceived as a possible explanation for the effects of mutations that change the conserved cysteines in Nop2p, an apparent RNA m(5)C methyltransferase that is essential for ribosome assembly and yeast viability. Evidence for the predicted accumulation of protein-RNA complexes following mutation of the assisting cysteine has been obtained with Nop2p and a known tRNA m(5)C methyltransferase called Ncl1p (Trm4).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220187     DOI: 10.1021/bi026055q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  55 in total

Review 1.  Probing the intermediacy of covalent RNA enzyme complexes in RNA modification enzymes.

Authors:  Stephanie M Chervin; Jeffrey D Kittendorf; George A Garcia
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

2.  miCLIP-MaPseq Identifies Substrates of Radical SAM RNA-Methylating Enzyme Using Mechanistic Cross-Linking and Mismatch Profiling.

Authors:  Vanja Stojković; David E Weinberg; Danica Galonić Fujimori
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Diversity in mechanism and function of tRNA methyltransferases.

Authors:  William E Swinehart; Jane E Jackman
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

4.  Transcriptome-wide target profiling of RNA cytosine methyltransferases using the mechanism-based enrichment procedure Aza-IP.

Authors:  Vahid Khoddami; Bradley R Cairns
Journal:  Nat Protoc       Date:  2014-01-16       Impact factor: 13.491

5.  Cysteine of sequence motif VI is essential for nucleophilic catalysis by yeast tRNA m5C methyltransferase.

Authors:  Hélène Walbott; Clotilde Husson; Sylvie Auxilien; Béatrice Golinelli-Pimpaneau
Journal:  RNA       Date:  2007-05-02       Impact factor: 4.942

6.  Human DNMT2 methylates tRNA(Asp) molecules using a DNA methyltransferase-like catalytic mechanism.

Authors:  Tomasz P Jurkowski; Madeleine Meusburger; Sameer Phalke; Mark Helm; Wolfgang Nellen; Gunter Reuter; Albert Jeltsch
Journal:  RNA       Date:  2008-06-20       Impact factor: 4.942

7.  The nucleolar RNA methyltransferase Misu (NSun2) is required for mitotic spindle stability.

Authors:  Shobbir Hussain; Sandra Blanco Benavente; Elisabete Nascimento; Ilaria Dragoni; Agata Kurowski; Astrid Gillich; Peter Humphreys; Michaela Frye
Journal:  J Cell Biol       Date:  2009-07-13       Impact factor: 10.539

8.  Radical SAM-Mediated Methylation of Ribosomal RNA.

Authors:  Vanja Stojković; Danica Galonić Fujimori
Journal:  Methods Enzymol       Date:  2015-04-25       Impact factor: 1.600

Review 9.  Stereochemical mechanisms of tRNA methyltransferases.

Authors:  Ya-Ming Hou; John J Perona
Journal:  FEBS Lett       Date:  2010-01-21       Impact factor: 4.124

Review 10.  5-methylcytosine in RNA: detection, enzymatic formation and biological functions.

Authors:  Yuri Motorin; Frank Lyko; Mark Helm
Journal:  Nucleic Acids Res       Date:  2009-12-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.